Copyright Reports & Markets. All rights reserved.

Global Virus Like Particles Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Virus Like Particles Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Virus Like Particles Market Size Growth Rate by Product
      • 1.4.2 Adeno-Associated Virus
      • 1.4.3 HIV
      • 1.4.4 Hepatitis B Virus
      • 1.4.5 Hepatitis C Virus
      • 1.4.6 Other
    • 1.5 Market by End User
      • 1.5.1 Global Virus Like Particles Market Size Growth Rate by End User
      • 1.5.2 Vaccines
      • 1.5.3 Mycoviruses
      • 1.5.4 Virus Research
      • 1.5.5 Therapeutic and Imaging Agents
      • 1.5.6 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Virus Like Particles Market Size
      • 2.1.1 Global Virus Like Particles Revenue 2014-2025
      • 2.1.2 Global Virus Like Particles Sales 2014-2025
    • 2.2 Virus Like Particles Growth Rate by Regions
      • 2.2.1 Global Virus Like Particles Sales by Regions
      • 2.2.2 Global Virus Like Particles Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Virus Like Particles Sales by Manufacturers
      • 3.1.1 Virus Like Particles Sales by Manufacturers
      • 3.1.2 Virus Like Particles Sales Market Share by Manufacturers
      • 3.1.3 Global Virus Like Particles Market Concentration Ratio (CR5 and HHI)
    • 3.2 Virus Like Particles Revenue by Manufacturers
      • 3.2.1 Virus Like Particles Revenue by Manufacturers (2014-2019)
      • 3.2.2 Virus Like Particles Revenue Share by Manufacturers (2014-2019)
    • 3.3 Virus Like Particles Price by Manufacturers
    • 3.4 Virus Like Particles Manufacturing Base Distribution, Product Types
      • 3.4.1 Virus Like Particles Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Virus Like Particles Product Type
      • 3.4.3 Date of International Manufacturers Enter into Virus Like Particles Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Virus Like Particles Sales by Product
    • 4.2 Global Virus Like Particles Revenue by Product
    • 4.3 Virus Like Particles Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Virus Like Particles Breakdown Data by End User

    6 North America

    • 6.1 North America Virus Like Particles by Countries
      • 6.1.1 North America Virus Like Particles Sales by Countries
      • 6.1.2 North America Virus Like Particles Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Virus Like Particles by Product
    • 6.3 North America Virus Like Particles by End User

    7 Europe

    • 7.1 Europe Virus Like Particles by Countries
      • 7.1.1 Europe Virus Like Particles Sales by Countries
      • 7.1.2 Europe Virus Like Particles Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Virus Like Particles by Product
    • 7.3 Europe Virus Like Particles by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Virus Like Particles by Countries
      • 8.1.1 Asia Pacific Virus Like Particles Sales by Countries
      • 8.1.2 Asia Pacific Virus Like Particles Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Virus Like Particles by Product
    • 8.3 Asia Pacific Virus Like Particles by End User

    9 Central & South America

    • 9.1 Central & South America Virus Like Particles by Countries
      • 9.1.1 Central & South America Virus Like Particles Sales by Countries
      • 9.1.2 Central & South America Virus Like Particles Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Virus Like Particles by Product
    • 9.3 Central & South America Virus Like Particles by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Virus Like Particles by Countries
      • 10.1.1 Middle East and Africa Virus Like Particles Sales by Countries
      • 10.1.2 Middle East and Africa Virus Like Particles Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Virus Like Particles by Product
    • 10.3 Middle East and Africa Virus Like Particles by End User

    11 Company Profiles

    • 11.1 GlaxoSmithKline
      • 11.1.1 GlaxoSmithKline Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 GlaxoSmithKline Virus Like Particles Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 GlaxoSmithKline Virus Like Particles Products Offered
      • 11.1.5 GlaxoSmithKline Recent Development
    • 11.2 Merck
      • 11.2.1 Merck Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Merck Virus Like Particles Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Merck Virus Like Particles Products Offered
      • 11.2.5 Merck Recent Development
    • 11.3 Novavax
      • 11.3.1 Novavax Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Novavax Virus Like Particles Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Novavax Virus Like Particles Products Offered
      • 11.3.5 Novavax Recent Development
    • 11.4 Takeda
      • 11.4.1 Takeda Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Takeda Virus Like Particles Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Takeda Virus Like Particles Products Offered
      • 11.4.5 Takeda Recent Development
    • 11.5 Medicago
      • 11.5.1 Medicago Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Medicago Virus Like Particles Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Medicago Virus Like Particles Products Offered
      • 11.5.5 Medicago Recent Development
    • 11.6 MedImmune
      • 11.6.1 MedImmune Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 MedImmune Virus Like Particles Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 MedImmune Virus Like Particles Products Offered
      • 11.6.5 MedImmune Recent Development
    • 11.7 TechnoVax
      • 11.7.1 TechnoVax Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 TechnoVax Virus Like Particles Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 TechnoVax Virus Like Particles Products Offered
      • 11.7.5 TechnoVax Recent Development
    • 11.8 Agilvax
      • 11.8.1 Agilvax Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Agilvax Virus Like Particles Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Agilvax Virus Like Particles Products Offered
      • 11.8.5 Agilvax Recent Development
    • 11.9 Allergy Therapeutics
      • 11.9.1 Allergy Therapeutics Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Allergy Therapeutics Virus Like Particles Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Allergy Therapeutics Virus Like Particles Products Offered
      • 11.9.5 Allergy Therapeutics Recent Development
    • 11.10 Serum Institute of India
      • 11.10.1 Serum Institute of India Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Serum Institute of India Virus Like Particles Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Serum Institute of India Virus Like Particles Products Offered
      • 11.10.5 Serum Institute of India Recent Development
    • 11.11 GeoVax Labs
    • 11.12 Cytos Biotechnology
    • 11.13 ANGANY Genetics
    • 11.14 CPL Biologicals
    • 11.15 Xiamen Innovax Biotech

    12 Future Forecast

    • 12.1 Virus Like Particles Market Forecast by Regions
      • 12.1.1 Global Virus Like Particles Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Virus Like Particles Revenue Forecast by Regions 2019-2025
    • 12.2 Virus Like Particles Market Forecast by Product
      • 12.2.1 Global Virus Like Particles Sales Forecast by Product 2019-2025
      • 12.2.2 Global Virus Like Particles Revenue Forecast by Product 2019-2025
    • 12.3 Virus Like Particles Market Forecast by End User
    • 12.4 North America Virus Like Particles Forecast
    • 12.5 Europe Virus Like Particles Forecast
    • 12.6 Asia Pacific Virus Like Particles Forecast
    • 12.7 Central & South America Virus Like Particles Forecast
    • 12.8 Middle East and Africa Virus Like Particles Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Virus Like Particles Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Virus Like Particles market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Virus Like Particles market based on company, product type, end user and key regions.

      This report studies the global market size of Virus Like Particles in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Virus Like Particles in these regions.
      This research report categorizes the global Virus Like Particles market by top players/brands, region, type and end user. This report also studies the global Virus Like Particles market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      GlaxoSmithKline
      Merck
      Novavax
      Takeda
      Medicago
      MedImmune
      TechnoVax
      Agilvax
      Allergy Therapeutics
      Serum Institute of India
      GeoVax Labs
      Cytos Biotechnology
      ANGANY Genetics
      CPL Biologicals
      Xiamen Innovax Biotech

      Market size by Product
      Adeno-Associated Virus
      HIV
      Hepatitis B Virus
      Hepatitis C Virus
      Other
      Market size by End User
      Vaccines
      Mycoviruses
      Virus Research
      Therapeutic and Imaging Agents
      Other

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Virus Like Particles market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Virus Like Particles market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Virus Like Particles companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Virus Like Particles submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Virus Like Particles are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Virus Like Particles market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now